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mtDNA HAPLOGROUPS AND SERUM LEVELS OF SOD2, CATALASE
AND GELSOLIN: ROLE IN OSTEOARTHRITIS
I. Rego-Pe´rez1, M. Ferna´ndez-Moreno1, S. Pe´rtega2, C. Ferna´ndez-Lo´pez1,
N. Oreiro1, V. Bonome3, F.J. Blanco1. 1INIBIC-CHUAC. Rheumatology Div.,
A Corun˜a, Spain; 2Epidemiology Unit. INIBIC-CHUAC, A Corun˜a, Spain;
3Centro de Salud Matogrande – SERGAS, A Corun˜a, Spain
Purpose: To measure the serum levels of Manganese Superoxide
dismutase (SOD2), Catalase and Gelsolin in order to evaluate their
possible application as hypothetical biomarkers in OA together with
the mtDNA haplogroups.
Methods: Serum concentrations of SOD2, Catalase and Gelsolin were
measured by enzyme-linked immunosorbent assays (ELISAs) in 150
samples from Hospital Universitario A Corun˜a (77 healthy controls and 73
OA patients). Knee and hip radiographs from the subjects were classiﬁed
according to Kellgren and Lawrence (K/L) scoring from Grade 0 to Grade
IV. Appropriated statistical approaches were carried out in order to
assess the incidence of diagnosis and haplogroups, as well as other
clinical variables, such as radiologic grade, gender, age and body mass
index (BMI), on serum levels of the described enzymes.
Results: Serum levels of SOD2 were signiﬁcantly increased in
OA patients (36378.36±11161.54) compared with healthy controls
(20830.11±30811.08), regardless of gender, age and BMI (p < 0.001),
and the higher the radologic grade, the higher the serum levels
of SOD2 (p < 0.001). Serum concentration of Catalase showed a non
signiﬁcant trend towards higher levels in OA patients (21.88±40.94)
compared to healthy controls (14.50±27.68), as well as increased
levels in carriers of mtDNA haplogroup J (p = 0.027). Finally, serum
levels of gelsolin, an actin-binding protein related to oxidative stress
and inﬂammation, appeared signiﬁcantly decreased in OA patients
(500999±43888.70) compared to healthy controls (511752.99±49709.35)
(p = 0.008), and signiﬁcantly increased in carriers of the haplogroup U
(520178.68±38409.87) (p = 0.015).
Conclusions: The results obtained support that local inﬂammation and,
specially, oxidative stress are key processes in the OA disease, and SOD2
appears as a candidate biomarker for prognosis of OA. The inﬂuence of
the mtDNA haplogroups on serum levels of Catalase and Gelsolin could
arise from the described different performance of the OXPHOS system
among the mtDNA haplogroups.
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SIMULATIONS TO ASSESS THE BEHAVIOR OF ORDERED VALUES FOR
CHANGES IN KNEE CARTILAGE THICKNESS IN CLINICAL DRUG TRIALS
R. Buck. StatAnswers Consulting LLC, Minnetonka, MN, USA
Purpose: Change in cartilage thickness is an important aspect of
osteoarthritis progression and is considered an alternative to joint
space narrowing as a proof of concept efﬁcacy endpoint. Detecting
differences in population change between two or more cohorts with
different exposures is a fundamental hypothesis in clinical trials for
assessing treatments. Ordered values of change in cartilage thickness
have been shown to be sensitive in detecting differences in thickness
change between two cohorts, but the properties of this new metric have
not been examined under conditions that mimic efﬁcacy trials. The goal
of this study was to assess ordered values of knee cartilage thickness
change through the use of simulated clinical trials.
Methods: Simulation models were based on parametric models, i.e.,
they were based on theoretical distributions and estimates of population
characteristics, or resampling of study data with adjustments to reﬂect
beliefs about drug effects in a clinical trial. Three classes of simulation
were examined:
1. Null case: Models with no difference between drug and placebo group
were used to assess whether tests using ordered values show test
bias, i.e., whether observed rate of statistical signiﬁcance under the
null hypothesis is different from the chosen Type I error for each
individual simulated test.
2. Experimental models: Examined the effect of population characteris-
tics, e.g., location and magnitude of change, on the sensitivity (power)
for hypothesis tests (t and Wilcoxon rank-sum test) for change at
ﬁxed location regions and ordered values. These simulation models
were constructed to exercise population characteristics rather than
simulate realistic scenarios.
3. Observational models: Simulation models were constructed to
examine 3 characteristics of drug effect: a reduction in proportion
and/or magnitude change in fast progressors in the study population,
and a general reduction in the magnitude of change (decline) in all
subjects. Observational models were either resampling of OAI data at
baseline and Year 2 or used parameters based on this data.
The models cover conditions where differences exist in: ﬁxed or random
location for change in basic subpopulation; a ﬁxed or random location
for a fast progressor subpopulation; more than one random location for
change in a fast progressor subpopulation. The basic subpopulation was
based on distribution characteristics of OAI Incidence cohort.
Results: Results for the null case indicate that the t and Wilcoxon rank-
sum tests were negligibly biased (proportion signiﬁcant when a =0.05
ranged from 0.033–0.061). The ﬁxed location method was more powerful
than the ordered values approach if change was restricted to the basic
subpopulation. The ordered values approach was more powerful when
fast progressors (thinning only) were present and change varied in
location between individuals in the study. The two methods were equally
sensitive when change was at ﬁxed location and fast progressors were
present. Test sensitivity was generally comparable for t and Wilcoxon
rank-sum tests, but t tests were more powerful in some cases.
Conclusions: Testing based on ordered values method appears to be
unbiased and is more sensitive than ﬁxed location approach when fast
progressors are present. Improved understanding of fast progressors in
the population may be needed to optimize knee cartilage thickness
change metrics in clinical trials.
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TURNOVER OF SEVERAL DIFFERENT METALLOPROTEINASE DERIVED
COLLAGEN SPECIES – A JOINT BIOCHEMICAL MARKER PANEL
A-C. Bay-Jensen, D.J. Leeming, M.A. Karsdal. Nordic BioSci. A/S, Herlev,
Denmark
Purpose: Joint degenerative diseases (JDD) are not only characterized by
cartilage degradation, but it also affects the surrounding tissues such as
muscle, bone and ligaments. In addition, it is known that both low and
high grade inﬂammation associated with JDD affect several tissues in the
body. Speciﬁc metalloproteinase (MMP) derived collagen fragments are
released upon JDD to the circulation and measurement of those might
give insight into tissue turnover upon JDD. The aim of the study was to
investigate the diagnostic value of ﬁve novel assays measuring different
collagen species. Ankylosing Spondylitis (AS) is characterized by gradual
cementation of the vertebrae, a process which is described by excessive
extracellular matrix remodeling of cartilage, bone and connective tissues.
It was therefore interesting to investigated the level of different collagen
species in AS.
Methods: Five newly developed ELISAs measuring MMP-degraded
collagen fragments (neoepitopes) in serum of 40 AS patients and 40
age-matched controls were measured; Collagen type I (CO1), type II
(CO2), type III (CO3), type IV (CO4) and type VI (CO6) as well as the bone
formation marker osteocalcin.
Results: The levels of the ﬁve collagen neoepitopes were signiﬁcantly
higher in AS patients, except for osteocalcin. Cartilage degradation (CO2)
was only signiﬁcantly correlated with the basement membrane (CO4)
in the AS patients. In contrast, CO3 was signiﬁcantly correlated with all
of the other collagen neoepitope markers. The highest diagnostic value
was achieved when combining the CO2, CO3 and CO6 markers, AUC
87% (p < 0.0001) and an odds-ratio of 15.6. Moreover, when combining
markers there was a correlation with the clinical mSASS score (P < 0.01,
R = 0.439)
Conclusion: Novel and unique biomarkers of tissue remodeling may
provide diagnostic value and aid in understanding of the AS pathology.
Each of the biomarkers tells a unique story and by combining them in
a panel there, we found a strong correlation with the clinical score. We
speculate that such panel will be a valuable tool for monitoring patients
as effect of treatment, for prediction of responders and for diagnostic
purposes for many JDD.
